The cost of US pharmaceutical price regulation: A financial simulation model of R&D decisions

Managerial and Decision Economics

Volumn 28, Issue 4-5, 2007, Pages 293-306

  Abbott, Thomas A ^a   Vernon, John A ^b,c  

^a MEDSTAT GROUP   (United States)

^b UNIVERSITY OF CONNECTICUT   (United States)

^c NATIONAL BUREAU OF ECONOMIC RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 34548355134     PISSN: 01436570     EISSN: 10991468     Source Type: Journal    
DOI: 10.1002/mde.1342     Document Type: Article

References (15)

1. Abel AB, Dixit AK, Eberly JC, Pindyck RS. Options, the value of capital, and investment. Quarterly Journal of Economics 111(3): 753-777.
2. Coulson NE, Stuart BC. 1995. Insurance choice and the demand for prescription drugs. Southern Economic Journal 61: 1146-1157.
3. Danzon PM. 2000. Making sense of drug prices. Regulation 23(1).
4. DiMasi JA. 1995. Success rates for new drugs entering clinical testing in the United States, Clinical Pharmacology and Therapeutics 8(1).
5. DiMasi JA, Hansen RW, Grabowski HG. 2003. The price of innovation: new estimates of drug development costs. Journal of Health Economics 22: 151-185.
6. Giaccotto C, Santerre RE, Vernon JA. 2005. Pharmaceutical pricing and R&D growth rates. Journal of Law and Economics, forthcoming.
7. Grabowski HG. 1994. Health Reform and Pharmaceutical Innovation. The AEI Press: Washington, DC.
8. Grabowski HG, Vernon JM. 1981. The determinants of R&D expenditures in the pharmaceutical industry. In Drugs and Health, Helms R (ed.). AEI Press: Washington, DC.
9. Grabowski HG, Vernon JM. 1990. A new look at the risks and returns to pharmaceutical R&D. Management Science 36(7): 804-821.
10. Grabowski HG, Vernon JM. 2000a. The determinants of pharmaceutical research and development expenditures. Journal of Evolutionary Economics 10: 201-215.
11. Grabowski HG, Vernon JM. 2000b. The distribution of sales revenues from pharmaceutical innovation. Pharmacoeconomics 18(Suppl. 1): 21-32.
12. Nelson R, Winter SG. 1982. An Evolutionary Theory of Economic Change. Harvard University Press: Cambridge, MA, London, UK.
13. Scherer FM. 2001. The link between gross profitability and pharmaceutical R&D spending. Health Affairs 20: 216-220.
14. Vernon JA. 2003. Simulating the impact of price regulation on pharmaceutical innovation. Pharmaceutical Development and Regulation 1(1): 55-65.
15. Vernon JA. 2005. Examining the link between price regulation and pharmaceutical R&D investment. Health Economics 14(1): 1-17.